Population
Subjects with abetalipoproteinemia (n=3) and normal subjects (n=3)
Design
Case-control
Authors
Loading...
Characterizes HDL2 predominance and enlargement in abetalipoproteinemia; leaves open whether these particles alter cardiovascular risk or guide therapy.
The absence of cholesteryl ester transfer to triglyceride-rich lipoproteins in abetalipoproteinemia leads to the accumulation of abnormally large, cholesteryl ester-rich HDL particles.
Deckelbaum et al. (1982) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: